𝔖 Bobbio Scriptorium
✦   LIBER   ✦

40 KDA peginterferon alfa-2A (PEGASYS®) in combination with ribavirin in African American and Caucasian patients with HCV genotype 1: a preliminary report of a comparative, multicenter, efficacy and safety study: Lennox J Jeffers, Miami VA Medical Center, Miami, FL; William Cassidy, Louisiana State University Health Sciences Center, Baton Rouge, LA; Charles Howell, University of Maryland School of Medicine, Baltimore, MD; K. Rajender Reddy, University of Miami School of Medicine, Miami, FL; Michael Fallon, University of Alabama, Birmingham, AL; Michael Dragutsky, Gastroenterology Center of the MidSouth, PC, Memphis, TN; George E Harb, Talia Biran, Roche Laboratories Inc, Nutley, NJ


Book ID
118688997
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
200 KB
Volume
34
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.